Synvisc-one syringe 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7MNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,710
Award facts
- Contract value 100% obligated
- $16,710.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,710.14 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. The contract, issued on December 2, 2025, with completion scheduled for December 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal contracting relationships with the Defense Logistics Agency for medical supply procurement supporting military and veteran healthcare systems. The company demonstrates broad capability in delivering pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Synvisc-One represents one of numerous competitively awarded transactions executed under AmerisourceBergen's prime IDC with DLA, reflecting the company's role as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7MNN?
SPE2DR26F7MNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F7MNN worth?
The government has obligated $16,710 on SPE2DR26F7MNN.
Is contract SPE2DR26F7MNN an order under another contract?
Yes. SPE2DR26F7MNN is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MNN competed?
The extent of competition for SPE2DR26F7MNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award